// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Early impairment of metabolic-oxygenation reactivity index relates to neurological outcome following neonatal encephalopathy.

Kelly Harvey-Jones - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

N/A

Incidental findings on 3T brain MRI at term-equivalent age in a research cohort of very preterm infants and term-born controls

Gemma Sullivan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increased numbers of COVID-19-related maternal and neonatal deaths during the Delta wave of SARS-CoV-2 infection in the United Kingdom

Chris Gale - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Individual metabolite impairment in cerebral deep grey matter relates to outcome following neonatal encephalopathy

Alan Bainbridge - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

Glutamine

Is Early Inhaled Nitric Oxide Beneficial in the Treatment of Neonates with Congenital Diaphragmatic Hernia?

Caroline Yeon-Kyeong Noh - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Congenital diaphragmatic hernia

INO

Is it possible for a family income supplement in early childhood to reduce developmental inequities?

Sharon Goldfeld - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Machine Learning Algorithm for Prediction of Neonatal Mortality in Zambia

Albert Manasyan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

Dexamethasone

Magnetic resonance assessment of hypothermic neuroprotection amongst babies born inside or outside of a cooling centre: a secondary analysis of the HELIX Trial

Phoebe Ivain - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Encephalopathy

N/A

Multi-disciplinary Team Facilitated Education Sessions for Families: Changing NICU Culture and Improving Family Experience

Mary-Rose Ballard - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neonatal regional outreach education in Quebec – a formal needs assessment

Michael-Andrew Assaad - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence and risk factors of vulnerable newborn phenotypes in rural Amhara, North West Ethiopia

Estifanos Baye - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Prevalence of bacteremia in febrile children with cancer: Is a peripheral culture necessary?

Mohamed Radwan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Procedural success and its determinants during minimally invasive surfactant therapy

Peter A. Dargaville - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Poractant alfa

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Acetaminophen

Success of blinding a procedural intervention from treating clinicians in a randomised controlled trial (RCT) in preterm infants with respiratory distress syndrome

Peter A. Dargaville - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Three-tissue decomposition of the neonatal brain using diffusion MRI

Manuel Blesa - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Titel: Umbilical cord clamping practice and vertical mother-newborn transmission during the COVID-19 pandemic – A systematic review.

Johan Berg - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Umbilical cord clamping practice recommendations in mothers with suspected or confirmed Coronavirus 19 disease – A systematic review of guidelines.

Johan Berg - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Unreliability of Procalcitonin in the diagnosis of Neonatal Sepsis in the tropics.

Nonye I. Ezeh - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Malaria

N/A

Utility of Urine Testing for the Detection of Asymptomatic Urinary Tract Infections in Pediatric Patients with Cancer: A retrospective chart review

Rasha D. Sawaya - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Urology

Urinary tract infections

N/A

Copyright © 2026. QuantiNova All rights reserved